UF Health Neuromedicine

UF Health Neuromedicine At UF Health Neuromedicine, we are dedicated to providing technically superb, compassionate and timely neurosurgical and neurological care for our patients.

10/22/2025

GAINESVILLE, Fla. — Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived…

08/25/2025

Congratulations to MBI researcher Dr. Michael Jaffee, named chair of Brain Injury Association of America's new Brain Injury Action Coalition, which will identify new solutions and accelerate advancements in treatment & prevention.

“For too long, brain injury has been understudied and underfunded. It is of vital importance that we have all parties at the table to advocate for a National Plan of Action that addresses the challenges that the brain injury community is facing, and I am excited to lead this effort,” said Jaffee, chair of UF Neurology.

Read more: bit.ly/4oOhChP

08/12/2025

In Pharmacological Reviews, MBI researchers Drs. Nancy Padilla-Coreano and Freddyson Martínez-Rivera examine dopamine’s role in social behaviors and how its dysfunction in neuropsychiatric disorders such as autism could influence social interactions.

“Neuropsychiatric and neurological disorders impact social behaviors, which results in reduced quality of life,” Padilla-Coreano said. “Current treatments for social dysfunctions are limited by our lack of knowledge regarding how the brain regulates and controls social interactions.”

Read more: bit.ly/4m7Hkwf

07/17/2025

Our latest MBI Researcher Highlight features Dr. Paola Giusti-Rodriguez, a University of Florida assistant professor of psychiatry who studies genetic psychiatric disorders and neurodevelopmental disorders. An investigator with UF’s Center for OCD, Anxiety and Related Disorders, Giusti-Rodriguez hopes to advance understanding of conditions including autism and schizophrenia.

Learn more: bit.ly/457XGP6

07/17/2025

MBI neuroscientists have discovered that dopamine neurons malfunction well before Parkinson's symptoms appear, opening a critical window for early intervention.
Published in npj Parkinson's Disease, the study reveals how the protein α-synuclein disrupts activity of dopamine neurons well before movement problems develop. This could transform treatment in the future by targeting the disease before irreversible damage occurs.

Read our latest MBI Research Snapshot: bit.ly/3Ug1mrO

Address

1505 SW Archer Road
Gainesville, FL
32608

Website

Alerts

Be the first to know and let us send you an email when UF Health Neuromedicine posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to UF Health Neuromedicine:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

UF Health – Neuromedicine

At UF Health Neuromedicine, we are dedicated to providing technically superb, compassionate and timely medical care for our patients. We are committed to the education of resident physicians and continuing medical education for practicing physicians in the art and science of neuromedicine. We are always exploring and developing — through clinical and basic research at the Evelyn F. and William L. McKnight Brain Institute at the University of Florida — new and better treatments for neurological and neurosurgical disorders.

Excellence in patient care


  • Preston A. Wells Jr. Center for Brain Tumor Therapy

  • UF Health Shands Comprehensive Stroke Center